US Food Recall Atlas

A single recall record, as the agency published it.

Recall mapAll recalls → F-1338-2013

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles. Nexgen Pharma, Inc. · reported 2013-05-01

Terminated This recall has been closed out by the agency.

Reason for recall
Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Classification
Class III
Recall initiated
2013-04-15
Reported by the agency
2013-05-01
Closed out (terminated)
2013-09-06
Recalling firm
Nexgen Pharma, Inc.
Colorado Springs, CO
United States

This is the firm that issued the recall — commonly a distributor or processor. It is not the origin of contamination.

Distribution (the agency's own words)
Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).
States we parsed from that text
AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WYour expansion

The agency wrote a broader phrase; these state names are ours, not theirs. Parse method nationwide, confidence high.

Food category
Dietary supplementsderived

Assigned by a reviewed keyword rulebook over the product description, not by the agency.

Recall type
Voluntary: Firm initiated
Recall number
F-1338-2013

This page reproduces a record published by the US Food and Drug Administration. It is not real-time: recalls typically appear in FDA's Enforcement Report weeks after they begin — a median of 40 days, see publication lag. For current food safety information consult FDA and USDA FSIS directly.